PureTech Health plc

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Site Specific
    • Vaccines
    • Specialty Pharmaceuticals
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule

Other Names/Subsidiaries

  • Vedanta Biosciences, Inc.
  • Alivio Therapeutics, Inc.
  • resTORbio, Inc.
  • Tal Medical
  • Alivio Therapeutics
  • Folica, Peerin, Mandara Sciences, resTORbio, Sonde Health, Tal Medical, Enlight Biosciences, Karuna Pharmaceuticals, Vedanta Biosciences
  • Gelesis
  • Glyph Biosciences
See more in Biomedtracker

Latest on PureTech Health plc

Scrip

PureTech’s IPF Candidate Ready For Phase III After Efficacy Win

 
• By Andrew McConaghie

PureTech’s idiopathic pulmonary fibrosis (IPF) candidate, deupirfenidone, is ready to enter a pivotal study after showing improved efficacy compared with standard treatment in a Phase II study. The pr

Scrip

PureTech Weighs Up Pros And Cons Of Going Private

 
• By Kevin Grogan

It looks as though nothing will come of the takeover talks PureTech Health has held with Nordic Capital Epsilon but there is a compelling argument for taking its ‘hub-and-spoke’ business private in th

Scrip

Spotlight On IPF Successors To Esbriet And Ofev

 
• By Kevin Grogan and Alexandra Shimmings

The busy week for the idiopathic pulmonary fibrosis (IPF) space has continued apace with the news that Roche is selling off rights to one of the two drugs currently approved for the debilitating and f

Scrip

ELEVATE Data Raise PureTech’s IPF Prospects

 
• By Kevin Grogan

PureTech Health’s bid to change the treatment paradigm for idiopathic pulmonary fibrosis (IPF) has been boosted by mid-stage data on its candidate that appears to have overcome the tolerability issues